Using a combination of demographic and clinical data gathered from seven weeks of COVID-19 patient care early in the coronavirus pandemic, Johns Hopkins researchers published a "prediction model" they say can help other hospitals care for COVID-19 ...
A pioneering blood test developed by Johns Hopkins researchers in the US, that makes cancer detection a part of routine medical care has received the largest investment ever for a Johns Hopkins-licensed technology.
Sweetch, the mobile-health app that helps prevent and improve outcomes in diabetes by encouraging long-term behavioral change, today revealed the outcomes of its clinical trial conducted at Johns Hopkins University